Invention is an essential feature of business. The best inventions are created when you mix talented people playing to their strengths in an environment of open collaboration, working in partnership with clients and suppliers with a clear focus on commercial goals.
Exciting and varied work that makes a difference. A collaborative culture where you can take on complex technical challenges and deliver commercial impact. That's life at TTP.
Whilst microfluidic devices have huge potential, most fail to progress beyond research use, let alone reach mass consumer markets similar to products in the microelectronics industry. But developers are increasingly using cycles of (1) optimised designs, (2) apt manufacturing, and (3) robust testing to create highly integrated and compact devices with exciting functionality for widespread application.
Testing an automation system, a robot or a complex high-value machine for reliability is a long, expensive, and challenging part of product development. Simon Shakespeare sees a future where product design for reliability is increasingly informed by simulations and statistical approaches to testing, giving engineers confidence in a design before any hardware prototype has been committed to production.
This blog looks at the impact of orbit and operating frequency on the types of IoT service a satellite operator can deliver. Paying attention to IoT network topology and air-interface protocols will enable all operators to make the most of the dish in front of them, says Steve Baker.
Intravenous delivery remains the dominant paradigm in oncology, but even with precision medicine few drugs pass late stage clinical trials. Karthik Chellappan proposes that early exploration of better administration routes could make all the difference.
From simple and standalone to complex and connected, visit our team of medical device experts at booth G02 to start the conversation.
Alexander Carr, consultant at TTP plc, contributes to the latest Biocompare Article. Super resolution microscopy (SRM) takes the resolution of optical microscopy below the diffraction limit of light.
TTP plc (TTP), a leading independent technology and product development company, has successfully demonstrated a reverse transcriptase-free RNA detection method.
TTP plc, a leading independent technology and product development company, and the Medical Research Council (MRC) will co-fund a PhD student at Imperial College London to develop new tools for production of cell therapies and cell-based products.
